Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IBEX Limited

IBEX Limited (IBEX) Stock Overview

Explore IBEX Limited’s financial performance, market position, analyst ratings, and future outlook.

IBEX●NASDAQ
TechnologyInformation Technology Services
$44.52
$1.36(3.15%)
U.S. Market opens in 35h 2m

IBEX Limited (IBEX)

Meyka AI Score

Z

Key Financials

Market Cap594.5M
P/E Ratio12.90
EPS (TTM)$3.55
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$43.73
3 Months$39.88
1 Year Target$40.77

IBEX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IBEX Limited (NASDAQ: IBEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IBEX Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IBEX on the NASDAQ shows an RSI of 67.79, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $40.77 for the NASDAQ listing.

Key metrics behind IBEX Limited's NASDAQ-traded stock include a P/E ratio of 12.90 and a market capitalization of 594.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBEX on the NASDAQ.

Price Performance (NASDAQ: IBEX)

1-Day Change
0.27%
5-Day Change
0.04%
1-Month Change
20.19%
3-Month Change
35.53%
6-Month Change
60.20%
Year-to-Date (YTD) Change
16.61%
1-Year Change
15.46%
3-Year Change
172.63%
5-Year Change
158.99%
All-Time (Max) Change
189.09%

Contact Information

https://www.ibex.co
202 580 6200
1700 Pennsylvania Avenue NW, Washington, DC, 20006

Company Facts

350,000 Employees
IPO DateAug 7, 2020
CountryUS
Actively Trading

Frequently Asked Questions